Arch Biopartners Market Cap

Arch Biopartners has a market cap or net worth of $38.59 million as of March 6, 2026. Its market cap has decreased by -55.32% in one year.

Market Cap

38.59M

Enterprise Value

40.50M

Revenue

115.29K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.58

Market Cap Chart

Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 38.59M, an increase of 14.75%. That is a compound annual growth rate of 0.91%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	38.59M	-34.74%
Dec 31, 2025	59.13M	-32.56%
Dec 31, 2024	87.67M	25.12%
Dec 29, 2023	70.07M	-46.02%
Dec 30, 2022	129.79M	-23.83%
Dec 31, 2021	170.40M	138.05%
Dec 31, 2020	Pro	Pro
Dec 26, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 23, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ZIVO Bioscience	37.00M
Cell Source	41.50M
Vicapsys Life Sciences	48.56M
Harvard Apparatus Regenerative Technology	30.24M
Nuo Therapeutics	67.60M
HST Global	70.56M
Finch Therapeutics Group	21.28M
Provectus Biopharmaceuticals	20.59M

Market Cap Rankings